AI Article Synopsis
- Transbronchial needle aspiration (TBNA) is a technique used with flexible bronchoscopy to diagnose thoracic cancer, successfully identifying cancer in 70 out of 108 patients studied.
- In 46% of cancer cases, TBNA alone confirmed the diagnosis, and it also contributed crucial staging information in 29% of other cases that were confirmed by conventional methods.
- This method not only minimized the need for further invasive surgeries in 20% of patients but also showed no complications, making it a safe and cost-effective diagnostic option.
Article Abstract
Transbronchial needle aspiration has recently been adapted for use with the flexible bronchoscope. We studied 108 patients, who had a total of 110 aspirations performed, and diagnosed thoracic cancer in 70 cases. Transbronchial needle aspiration revealed malignant disease in 32 (46%) of these 70 patients. In 12 (17%) patients with cancer this technique provided the sole cytological or histological confirmation of the diagnosis. It gave a positive result in an additional 20 (29%) cases in which the diagnosis was also proved by conventional procedures, and it provided important staging information in these patients. In 20% of patients with cancer transbronchial needle aspiration precluded the need for further diagnostic surgery. There were no complications in this series. This is a safe, useful, and economical technique that can be used in diagnosing and staging patients with carcinoma of the lung.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC460179 | PMC |
| http://dx.doi.org/10.1136/thx.40.10.756 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Next-Generation Sequencing Analysis on Image-Guided Biopsy Samples in Early-Stage Lung Cancer: Feasibility Study and Comparison With Surgical Samples.
JTO Clin Res Rep
February 2025
Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Introduction: Limited information exists on next-generation sequencing (NGS) success for lung tumors of 30 mm or less. We aimed to compare NGS success rates across biopsy techniques for these tumors, assess DNA sequencing quality, and verify reliability against surgical resection results.
Methods: We used data from the Initiative for Early Lung Cancer Research on Treatment study, including patients with lung tumors measuring 30 mm or less who had surgery and NGS on biopsies since 2016.
Introduction: Around 85% of non-small cell lung cancers (NSCLCs) are diagnosed at an advanced stage (IIIB to IV), where therapeutic options depend on molecular analysis. However, diagnostic material for molecular testing is often represented by cytological samples which are generally scarce and span a wide range of preparation types. Thus, the primary objective is to efficiently manage materials for molecular profiling.
View Article and Find Full Text PDFCytomorphological diagnosis of sarcoidosis using EBUS-TBNA in a tuberculosis-endemic region.
Rev Esp Patol
January 2025
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Background: Sarcoidosis, a granulomatous inflammatory disease, exhibits diverse clinical manifestations, often affecting multiple organs. Diagnostic challenges arise due to its similarities with tuberculosis, particularly in high-burden areas. Differentiating between the two relies on clinical judgment, laboratory tests, imaging, and invasive procedures.
View Article and Find Full Text PDFMassive endobronchial hemorrhage leading to Cardiac arrest during EBUS-TBNA: a case of successful resuscitation.
BMC Pulm Med
January 2025
Department of Pulmonary and Critical Care Medicine, School of Medicine, Zhongshan Hospital of Xiamen University, Xiamen University, Xiamen, Fujian, China.
Introduction: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is commonly used for diagnosing mediastinal lymphadenopathy. Despite a low complication rate, severe hemorrhage can occur which is reported in this literature, particularly in hypervascular conditions like Castleman disease.
Methods: A 54-year-old male with idiopathic multicentric Castleman disease underwent EBUS-TBNA for mediastinal lymph node sampling.
Infective Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) and Clinical Biomarkers: A Concise Review.
Diagnostics (Basel)
January 2025
Department of Respiratory Medicine, Medical School, University of Patras, 26504 Patras, Greece.
EBUS-TBNA is the most common interventional pulmonology procedure performed globally and remains the cornerstone of the diagnosis and staging not only of lung cancer but also for other neoplastic, inflammatory, and infective pathologies of the mediastinum. Infective complications of EBUS-TBNA are underreported in the literature, but the constantly rising incidence of lung cancer is leading to an increasing number of EBUS-TBNA procedures and, therefore, to a significant number of infective complications, even 4 weeks following the procedure. In this review we attempt to summarize the risk factors related to these infective complications, along with useful biomarkers that can be used to identify patients that might develop infective complications, to facilitate the prediction or even prompt treatment of these.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!